Hiantis was founded in 2014 to turn into products ideas stemmed out of founders experiences and expertise inclinicalpractice and microbiological research
(Hiantis Mission is) to create products and services to help to improve people’s health, by preventing diseases, facilitating their diagnosis and improving their treatment, through the understanding of what is already known and the search for new knowledge
Founder and Hiantis Sole Administrator, Paolo is a Dermatologistwith experience in drug development and management from his previous work in Pharmaceutical Industry as Medical Director. He is inventor of patents regarding drug’s formulations in the field of bone and dermatological diseases and co-author of publications in international peer-reviewed scientific journals, in collaboration with Italian and International researchers. Bibliography
Co-Founder and Hiantis Scientific Adviser in Clinical Microbiology, Clementina is Associate Professor of Clinical Microbiology and Head of the Laboratory of Clinical Microbiology and Virology at the University of Milano-Bicocca. She has acquired extensive experience in clinical microbiology also by working in Microbiology Laboratories of international institutions such as The London Hospital Medical School, The Rockefeller University, New York, and The Rickettsial Laboratory of CDC, Atlanta.
She achieved a Medical Degree (MBBS), a Biochemistry Degree (BSc) and a Master Degree in Clinical Microbiology (MSc) at the University of London, as well as a PhD in Clinical Microbiology at the University of Milan. She is author of several papers published in high quality international peer reviewed scientific journals and co-inventor of EU patent that protects a diagnostic algorithm for HPV infections leading to cancer.
Planning and Technical Manager
Ivan is responsible for the product and strategic marketing implementation plans, driving the field penetration of new MDx CE-IVD Kits. In his past commitments, prior to joining Hiantis, he had trackable success in setting-up ISO-certified operative facilities,for both molecular IVD services (Bianalisi S.r.l) as well as kits development and production (Biodiversity Spa, Bird S.r.l). His experience and expertise contributes to bringing the molecular in-vitro diagnostics tools at the market level. In addition to the Master Degree in Molecular Biology (University of Milan) he obtained the Medical Specialization in Genetics (University of Brescia).
Head of Production
Marzia is responsible for the Kit Production and Quality Control process implementation and execution. She has specific tasks in the pre-industrialization phases leading to the HPV OncoPredict Kit realization. In her past commitments (Science Park of Trieste, San Raffaele in Milan) she worked on assay development gaining experience in molecular biology and the strong attitude to the problem solving. Marzia obtained her Master Degree in Functional Genomics and a PhD in Molecular Biomedicine at University of Trieste.
Silvia is responsible of specific tasks for the analytical development and validation of new batches of the HPV OncoPredict Kit. In charge of process implementation for kit labelling and all aspects related to the logistics and tracking control (kits/samples).Silvia obtained her Master Degree in Medical Biotechnology (University of Brescia) with strong skills in the field of molecular biology.
Illari is undertaking her PhD at the University of Sassari with specific research activities to be undertaken through industrial partnership. She is presently collaborating with Hiantis as a guest researcher working on the analytical and clinical validation of medical devices used for sample collection, DNA extraction, Real-Time PCR detection and automatic reporting. Illari has achieved a Master Degree in Experimental and Applied BiologyScience at the University of Sassari following which she gainedexperience by working as a clinical researcher in a diagnostics laboratory involved in the implementation ofan HPV Screening Regional Program.